Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma

We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to az...

Full description

Bibliographic Details
Main Authors: Kevin Cyrus Hong, Julius Schachter, Jeanne Moncada, Zhaoxia Zhou, Jenafir House, Thomas M. Lietman
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2009-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/15/7/08-1563_article
id doaj-63d4f3cf741a45058e862e268079d134
record_format Article
spelling doaj-63d4f3cf741a45058e862e268079d1342020-11-25T02:46:34ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592009-07-011571088109010.3201/eid1507.081563Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for TrachomaKevin Cyrus HongJulius SchachterJeanne MoncadaZhaoxia ZhouJenafir HouseThomas M. LietmanWe investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to azithromycin and doxycycline in 6 posttreatment and 4 pretreatment samples.https://wwwnc.cdc.gov/eid/article/15/7/08-1563_articleTrachomachlamydiaazithromycindoxycyclinemacrolidesantimicrobial resistance
collection DOAJ
language English
format Article
sources DOAJ
author Kevin Cyrus Hong
Julius Schachter
Jeanne Moncada
Zhaoxia Zhou
Jenafir House
Thomas M. Lietman
spellingShingle Kevin Cyrus Hong
Julius Schachter
Jeanne Moncada
Zhaoxia Zhou
Jenafir House
Thomas M. Lietman
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
Emerging Infectious Diseases
Trachoma
chlamydia
azithromycin
doxycycline
macrolides
antimicrobial resistance
author_facet Kevin Cyrus Hong
Julius Schachter
Jeanne Moncada
Zhaoxia Zhou
Jenafir House
Thomas M. Lietman
author_sort Kevin Cyrus Hong
title Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
title_short Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
title_full Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
title_fullStr Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
title_full_unstemmed Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
title_sort lack of macrolide resistance in chlamydia trachomatis after mass azithromycin distributions for trachoma
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2009-07-01
description We investigated antimicrobial drug resistance in ocular Chlamydia trachomatis 18 months after 4 biannual communitywide distributions of antimicrobial drugs in a region of Ethiopia where ocular strains of C. trachomatis are highly endemic. We found no significant differences in susceptibilities to azithromycin and doxycycline in 6 posttreatment and 4 pretreatment samples.
topic Trachoma
chlamydia
azithromycin
doxycycline
macrolides
antimicrobial resistance
url https://wwwnc.cdc.gov/eid/article/15/7/08-1563_article
work_keys_str_mv AT kevincyrushong lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
AT juliusschachter lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
AT jeannemoncada lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
AT zhaoxiazhou lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
AT jenafirhouse lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
AT thomasmlietman lackofmacrolideresistanceinchlamydiatrachomatisaftermassazithromycindistributionsfortrachoma
_version_ 1724757553972248576